Your browser doesn't support javascript.
loading
Education, employment, and income among people living with cystic fibrosis across three decades - A matched cohort study using Danish health registries.
Jensen, Camilla Bjørn; Jensen, Kristoffer Jarlov; Pressler, Tacjana; Katzenstein, Terese L; Skov, Marianne; Qvist, Tavs; Olsen, Mette Frahm; Jeppesen, Majbritt; Jensen-Fangel, Søren; Olesen, Hanne Vebert; Reuter, Simon Bertram; Pedersen, Hans Kristian Råket; Wang, Joanna Nan; Michalopoulos, Steven; McGarry, Lisa; Wöhling, Heike; Petersen, Janne; Jimenez-Solem, Espen.
Afiliación
  • Jensen CB; Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, University Hospital of Copenhagen - Bispebjerg and Frederiksberg, DK, Denmark. Electronic address: Camilla.Bjoern.Jensen@regionh.dk.
  • Jensen KJ; Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, University Hospital of Copenhagen - Bispebjerg and Frederiksberg, DK, Denmark.
  • Pressler T; Department of Infectious Diseases, University Hospital of Copenhagen - Rigshospitalet, Cystic Fibrosis Centre, DK, Denmark; Department of Pediatrics and Adolescent Medicine, University Hospital of Copenhagen - Rigshospitalet, Cystic Fibrosis Centre, DK, Denmark.
  • Katzenstein TL; Department of Infectious Diseases, University Hospital of Copenhagen - Rigshospitalet, Cystic Fibrosis Centre, DK, Denmark.
  • Skov M; Department of Pediatrics and Adolescent Medicine, University Hospital of Copenhagen - Rigshospitalet, Cystic Fibrosis Centre, DK, Denmark.
  • Qvist T; Department of Infectious Diseases, University Hospital of Copenhagen - Rigshospitalet, Cystic Fibrosis Centre, DK, Denmark.
  • Olsen MF; Department of Infectious Diseases, University Hospital of Copenhagen - Rigshospitalet, Cystic Fibrosis Centre, DK, Denmark; Department of Nutrition, Exercise and Sports, University of Copenhagen, DK, Denmark.
  • Jeppesen M; Department of Infectious Diseases, Aarhus University Hospital, DK, Denmark.
  • Jensen-Fangel S; Department of Infectious Diseases, Aarhus University Hospital, DK, Denmark.
  • Olesen HV; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, DK, Denmark.
  • Reuter SB; Department of Clinical Pharmacology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, DK, Denmark.
  • Pedersen HKR; Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, University Hospital of Copenhagen - Bispebjerg and Frederiksberg, DK, Denmark; Department of Clinical Pharmacology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, DK, Denmar
  • Wang JN; Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, University Hospital of Copenhagen - Bispebjerg and Frederiksberg, DK, Denmark; Department of Clinical Pharmacology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, DK, Denmar
  • Michalopoulos S; Vertex Pharmaceuticals Incorporated, Boston, MA, USA.
  • McGarry L; Vertex Pharmaceuticals Incorporated, Boston, MA, USA.
  • Wöhling H; Vertex Pharmaceuticals Incorporated, Boston, MA, USA.
  • Petersen J; Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, University Hospital of Copenhagen - Bispebjerg and Frederiksberg, DK, Denmark; Section of Biostatistics, Department of Public Health, University of Copenhagen, DK, Denmark.
  • Jimenez-Solem E; Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, University Hospital of Copenhagen - Bispebjerg and Frederiksberg, DK, Denmark; Department of Clinical Pharmacology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, DK, Denmar
J Cyst Fibros ; 2024 Mar 14.
Article en En | MEDLINE | ID: mdl-38485602
ABSTRACT

BACKGROUND:

Past and ongoing advancements in cystic fibrosis (CF) care warrant long-term analysis of the societal impact of the condition. This study aims to evaluate changes in key socioeconomic factors across three decades among people living with CF (pwCF), compared with both the general population and an early-onset chronic disease population.

METHODS:

This nationwide, registry-based, matched cohort study included all pwCF ≥ 18 years in Denmark in the years 1990, 2000, 2010, and 2018. Each person living with CF was matched to five individuals in the general population and five individuals living with type 1 diabetes or juvenile arthritis based on age, sex, and municipality.

RESULTS:

The Danish adult CF population increased nearly fourfold from 88 in 1990 to 331 in 2018, and mean age increased by ten years. The educational level of pwCF was similar to the two comparator cohorts, while pwCF were less often in employment and more often permanently outside the labor force. Personal and household income levels of the CF cohort were higher than those of the comparator cohorts.

CONCLUSIONS:

The disadvantage in employment for pwCF remained, but, over time, the societal profiles of the one-year CF cohorts increasingly converged with those of the comparator cohorts, indicative of improved clinical management, extended life expectancy, and the supportive role of the Danish welfare system in reducing health inequalities. Further research should be done to evaluate the effects of the newly introduced modulator therapies on employment, considering the broader societal impact and impact on quality of life.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Cyst Fibros Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Cyst Fibros Año: 2024 Tipo del documento: Article